Biotech Breakthroughs
Invest in

Biotech Breakthroughs

18.9%
5.6%
0.4%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
18.9%
5.6%
0.4%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
28.7% Cancer 18.5%
16.7% Amgen Inc AMGN 14.4%
9.9% Celgene Corp. CELG 29.9%
1.2% Spectrum Pharmaceuticals Inc. SPPI 6.0%
1.0% Medivation Inc MDVN 2.9%
20.5% Autoimmune Disorders 25.0%
13.1% Biogen Inc BIIB 10.8%
3.5% BioMarin Pharmaceutical Inc. BMRN 88.0%
2.0% Incyte Corp. INCY 111.1%
1.0% Xencor Inc XNCR 67.4%
0.8% ACADIA Pharmaceuticals Inc. ACAD 60.6%
19.6% Other Diseases 33.3%
5.1% Regeneron Pharmaceuticals Inc. REGN 55.1%
4.7% Alexion Pharmaceuticals Inc. ALXN 6.8%
4.0% Vertex Pharmaceuticals Incorporated VRTX 44.1%
1.4% The Medicines Company MDCO 25.7%
1.2% Acorda Therapeutics Inc. ACOR 1.9%
1.2% Ophthotech Corp OPHT 17.6%
1.0% Alkermes plc ALKS 37.5%
1.0% Momenta Pharmaceuticals Inc. MNTA 71.8%
18.6% Infectious Diseases 11.6%
15.5% Gilead Sciences Inc. GILD 0.8%
1.7% Emergent Biosolutions Inc. EBS 37.8%
1.4% Chimerix Inc. CMRX 98.2%
12.6% Research & Diagnostics 15.8%
3.8% Quintiles Transnational Holdings Q 31.7%
3.6% Illumina Inc. ILMN 12.8%
2.9% Qiagen N.V. QGEN 11.5%
1.4% Meridian Bioscience Inc. VIVO 0.3%
0.9% Bio-Techne Corp TECH --